top of page

HD-tDCS as augmentation therapy in late-life depression (Cancelled)

Departmental Research Seminar

Presented by: 

Dr. Calvin Pak Wing CHENG

Chaired by:

Prof. Eric Yu Hai CHEN


30 January 2020


6:30 am


7:05 am


G/F, Room LG-S2, Laboratory Block, Faculty of Medicine Building


HD-tDCS has great potential as a new treatment option for depression based on its effects on neural plasticity and enhancement of serotonin and cognitive function. A previous meta-analysis suggested the effectiveness and tolerability in patients with depression, despite the conflicting results. The efficacy of HD-tDCS in patients with LLD remains unknown due to the scarcity of research.

Add Photo(s)
bottom of page